OralScan is a portable multispectral imaging device developed by SASCAN Meditech, designed for the early detection of oral cancer. It maps changes in tissue autofluorescence and oxygenated haemoglobin absorption — without the need for drugs, radiation, or electricity — making it deployable even in remote and resource-limited clinical settings. Equipped with cloud-based machine learning software, OralScan delivers real-time, quantitative tissue assessment and pinpoints the most malignant site for biopsy, significantly reducing false negatives and enabling earlier, more effective intervention.
Portable, handheld device — no external power source required
Multispectral optical imaging — no drugs, radiation, or contrast agents needed
Cloud-based AI/ML platform for real-time, quantitative tissue assessment
Identifies the most malignant site for targeted biopsy, reducing false negatives
Quick, pain-free screening process suited for community outreach and specialist clinics
Developed by SASCAN Meditech, with clinical validation across oncology settings
Seagull Healthcorp is the authorized distributor of OralScan by SASCAN Meditech in India. Our team works closely with oral oncology departments, ENT specialists, cancer screening programs, and public health institutions to ensure seamless access to this technology. We provide full clinical support, demonstration, and training to help healthcare providers deploy OralScan effectively across hospital and community settings.